Pediatric Cardiology and Adult Congenital Heart Disease group; dP/dt max was 999±253 mmHg/s at 120 min (p=0.016) and 854±209 mmHg/s at 180 min (p=0.054). Conclusion: Induced maternal hyperglycemia improves fetal cardiac function during fetal tachycardia.
Background
Technical advances and obstetrical education have greatly increased the use of Fetal Echocardiography (FE) over the past 10 years. Earlier studies showed that the major indications for FE included a family history of congenital heart disease (CHD), maternal diabetes and arrythmia. We hypothesized that the increased utilization of FE is associated with a change in indications and yield of FE. Methods We reviewed 300 consecutive FE performed at Stanford University between 12/2002 and 8/2003. Major anomaly was defined as that affecting prognosis. Chromosomal anomaly was defined either as suspected (based on ultrasound (US) findings) or proven (chromosomal analysis). Results Indications for FE and their yield are presented in the table.
Mean maternal age was 31±6 (range 16-44) years. Of 7 cases with increased nuchal thickening, 1 (14%), showed PA/IVS. No cardiac anomalies were found in the presence of an abnormal umbilical cord. Conclusions Indications for FE have changed over the last 10 years. An obstetrical US suspicious for CHD has become a prominent indication for FE, indicating an increased awareness of cardiac anomalies by obstetricians. This indication, together with chromosomal anomalies, accounts for a large percentage of positive FE. Thus, the yield of FE depends to a large extent on the skills of the obstetrician. Common indications that continue to have relatively low yield include maternal diabetes, arrhythmia and especially a family history of CHD and exposure to a teratogen.
1057-203 Ventricular Function in Fetal Congestive Heart Failure and Predictors of Perinatal Outcome
Masaki Nii, Mary van der Velde, Edward N. Marcus, Wendy Tsang, Lisa K. Hornberger, The Hospital for Sick Children, Toronto, ON, Canada, Children's Hospital, Boston, MA Background: Although the types of primary cardiac lesions associated with fetal congestive heart failure (CHF) are well recognized, there is a paucity of data which defines the associated abnormalities of ventricular function and predictors of outcome. We sought to determine the specific abnormalities of ventricular function and to identify ventricular functional parameters that may assist in predicting outcome in a large cohort of affected fetuses. Methods: We reviewed the initial fetal echocardiograms (mean age 25.2±5.2 weeks) and clinical histories of 87 fetuses with CHF due to structural heart disease (n=41), primary dysrhythmias (n=22) or primary myocardial disease (n=24). LV and RV shortening fraction (SF), and Tei indices were assessed where possible and compared to previously published normal data. Diastolic dysfunction was considered to be present when 1 or more of the following indices were abnormal: A/E ratio, deceleration time, LV-IVRT, IVC, DV and UV flow pattern. In continued pregnancies with known outcome, parameters were compared between those with fetal or neonatal demise (n=38) versus survivors (n=26 Background: This study evaluates outcome in a series of consecutive patients who were diagnosed prenatally with structural heart defects (SHD) and identifies factors associated with mortality in this cohort. Methods: Fetal echo reports at a single institution from August 1995 through November 2002 were reviewed. The following outcomes for fetuses with SHD were evaluated: families opting for no active management, hospital survival following surgery at initial admission, and survival at most recent follow up. Variables evaluated for potential association with these outcomes included cardiac diagnosis, gestational age at diagnosis and at birth, gender, birth weight, extracardiac and/or chromosomal anomalies, ethnicity, insurance status (a marker of socioeconomic status), surgery at initial admission, and univentricular versus biventricular management pathway. Univariate and multivariate analysis were performed. Results: We identified 168 fetuses with SHD, of whom 126 (75%) chose active treatment.
SV Repair (n = 8)
BV Repair (n = 8) vs. 0.37 ± 0.9 cm/s; p< 0.001), VTI r (1.3 ± 0.3 vs. 0.05 ± 0.08 cm; p<0.001) and %R (18.4 ± 4.0 % vs.0.8 ± 1.3%; p<0.001). D and VTI f showed no difference. Pair-wise comparison showed trend towards increase in S, S/D, A, VTIr and %R and decrease in D from HLHS-A to HLHS-C, with only A and S/D achieving statistical significance. Conclusions: PVD flow patterns are abnormal in HLHS even in the absence of restrictive ASD, suggesting that factors other than impaired left atrial egress play a role. The A velocity and S/D ratio correlate best with the degree of restriction, the latter being clinically most useful due to its independence from insonation angle. Further study of PVD patterns can provide important insights into fetal pulmonary vascular development in HLHS. Background: Occlusive devices for closure of patent ductus arteriosus (PDA) can protrude into the descending aorta in small infants. Coils can fit into the duct ampulla better but coil occlusion can be technically demanding. We present our experience in coil occlusion ducts in infants weighing less than or equal to 5kg. Methods: We reviewed our 5-year institutional database of all children undergoing catheter closure of PDA at our institution and identified all infants with weighing 5 Kg or lesser. Case selection was through echocardiography. Duct diameter of less than 5 mm and adequate size of ampulla were prerequisites Results: Forty-five (6%) of 752 children who underwent transcatheter occlusion of PDA were identified (median weight: 4.5 Kgs, range: 0.96-5 Kg; median age: 4 months; range: 18 days -12 months). The mean duct size was 3.2 ± 0.8 mm. Four infants were mechanical ventilated for heart failure with pneumonia. The procedure was successful in all (1.8±1.1 coils used /patient; fluoroscopy time: 11.4±8.5min). Bioptome assistance was used in 27 (60%) infants (multiple coils were delivered simultaneously in 14). Coil turns were cut to "fit the ampulla" in 20 (44%) patients. Arterial puncture was avoided in 25 (55%) patients. There were 6 episodes of embolization (all coils retrieved). Seven (16%) had small residual flow at the end of the procedure. All 4 infants on mechanical ventilation were successfully weaned off over 48-72 hours. On follow-up, 3 (6.6%) had a newonset Doppler gradient (24-32 mm Hg) across the LPA and 4 had trivial residual flow. There was no hemolysis or vascular complication. Conclusions: Coil occlusion of PDA is feasible as a less invasive option to surgery in selected small infants. The limitations of the procedure include the potential for embolization and occurrence of LPA stenosis in a small proportion of patients.
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1076-200 Differences in Pulmonary Artery Angioplasty by Proximal Versus Distal Dilation Sites
Lisa Bergersen, Barry Keane, Kimberlee Gauvreau, James Lock, Kathy Jenkins, Children's Hospital, Boston, MA Introduction: We sought to determine the acute efficacy, late efficacy, and adverse event rate for modern balloon technology and explore differences in procedure, techniques, and outcomes by dilation site, proximal vs. distal pulmonary artery (PA). Methods: Angiograms and medical records were reviewed in a random sample of 104 PA dilation procedures between 1/96 and 12/00. Differences in technique, adverse event rate, and acute and follow-up changes in lumen diameter were analyzed by dilation site. Results: Of 100 patients (diagnosis TOF 11, TOF/PA 35, PPS 16, Truncus 12, other 26) undergoing 104 procedures (proximal 55, distal 39, both 10), 203 vessels were dilated, 78 (38%) proximal (R or LPA) and 125 (62%) distal. High pressure balloons were more commonly used in distal angioplasty procedures (p<0.001). Median balloon size relative to minimum lumen diameter was larger for distal dilations, 2.7 vs 2.0 (p<0.001) for the first balloon and 2.9 vs. 2.7 (p=0.09) for the second balloon. Elimination of a waist with the first balloon angioplasty was more likely when dilating proximal vessels (78 vs 63%, p=0.03), but recoil was more frequent, requiring stent placement in 19 of 78 (24%) vs 2 of 125 (2%), p<0.001. For the 92 vessels with follow-up angiography, 9 (10%), CI [5%, 18%], experienced restenosis, defined as a return to pre-dilation diameter. Vessel trauma occurred in 11% of dilations (intravascular tear with flow obstruction in 11, confined tear in 8, and unconfined tear in 2) with no differences based on location. Other adverse events were also similar between the 2 groups, including cardiac arrest (1), hypotension (3), arrhythmias (5), and pulmonary edema (6). Vessel rupture occurred in 2 of 203 dilations (1%) and was successfully managed with coil embolization; no patients died. Conclusion: Distal vs Proximal PA angioplasty procedures differ in technique employed and expected outcome. Distal dilation sites required larger balloon to vessel ratios and were more often resistant to low pressure angioplasty. Proximal sites were more likely to experience recoil and require stent placement. Despite these differences, no differences in restenosis, vessel trauma or other adverse events were observed. 
